Drugs that contain Pasireotide Diaspartate

1. List of Signifor drug patents

Can you believe SIGNIFOR received compensation for the extended wait time during the regulatory approval process?
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8299209 RECORDATI RARE Pharmaceutical composition comprising cyclic somatostatin analogues
Dec, 2025

(2 years from now)

US7473761 RECORDATI RARE Somatostatin analogues
Dec, 2026

(3 years from now)

Market Authorisation Date: 14 December, 2012

Treatment: NA

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage

SIGNIFOR family patents

9

United States

4

European Union

3

United Kingdom

3

Norway

3

Korea, Republic of

3

Australia

2

Portugal

2

Germany

2

Malaysia

2

Russia

2

Spain

2

Brazil

2

New Zealand

2

Austria

2

Argentina

2

Mexico

2

Peru

2

China

2

Taiwan, Province of China

2

Hong Kong

2

South Africa

2

Japan

2

Canada

2

Cyprus

2

Slovenia

2

Israel

2

Poland

2

Ecuador

2

Denmark

1

Croatia

1

Colombia

1

Morocco

1

Belgium

1

Tunisia

1

Slovakia

1

Hungary

1

Luxembourg

1

Czech Republic

1

Iceland

1

Chile

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic